DOB-FLY

Psychedelic drug From Wikipedia, the free encyclopedia

DOB-FLY, also known as 3C-B-FLY or as B-FLY, is a psychedelic drug and designer drug of the phenethylamine, amphetamine, DOx, and FLY families. It is the FLY derivative of DOB, the amphetamine (α-methyl) derivative of 2C-B-FLY, and the partially saturated analogue of Bromo-DragonFLY (DOB-DFLY).

Other names3C-B-FLY; B-FLY; Bromo-FLY
Routes of
administrationOral
Drug classSerotonergic psychedelic; Hallucinogen
Legal status
  • In general unscheduled
Quick facts Clinical data, Other names ...
DOB-FLY
Clinical data
Other names3C-B-FLY; B-FLY; Bromo-FLY
Routes of
administration		Oral
Drug classSerotonergic psychedelic; Hallucinogen
Legal status
Legal status
  • In general unscheduled
Identifiers
  • 1-(4-bromo-2,3,6,7-tetrahydrofuro[2,3-f][1]benzofuran-8-yl)propan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC13H16BrNO2
Molar mass298.180 g·mol−1
3D model (JSmol)
  • CC(CC1=C2CCOC2=C(C3=C1OCC3)Br)N
  • InChI=1S/C13H16BrNO2/c1-7(15)6-10-8-2-4-17-13(8)11(14)9-3-5-16-12(9)10/h7H,2-6,15H2,1H3
  • Key:FKRREVSELFOLDT-UHFFFAOYSA-N
Close

Unlike Bromo-DragonFLY, DOB-FLY is only slightly more potent than DOB itself, with an active dose in humans of around 1 mg orally (compared to 1–3 mg orally for DOB).[1][2][3][4][5][6]

Analogues of DOB-FLY include DOB, 2C-B-FLY, Bromo-DragonFLY (DOB-DFLY), TFMFly (TFM-FLY), and DOB-5-hemiFLY, among others.

DOB-FLY was developed by David E. Nichols and colleagues at Purdue University. It is a controlled substance in Canada under phenethylamine blanket-ban language,[7] but is not explicitly controlled in the United States.[8]

See also

References

External links

Related Articles

Wikiwand AI